Pharma Equity Group A/S (PEG) indgår aftale med Danske Bank om udøvelse af prisstillelse (Market Maker) i PEG aktien, fondskode: DK0061155009
March 22, 2024 04:00 ET
|
Pharma Equity Group A/S
Dato: 22. marts 2024 Årets meddelelse nr. 09 Pharma Equity Group A/S (PEG) indgår aftale med Danske Bank om udøvelse af prisstillelse (Market Maker) i PEG aktien, fondskode: DK0061155009 Pharma...
Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009
March 22, 2024 04:00 ET
|
Pharma Equity Group A/S
Date: 22 March 2024 Announcement of the Year No. 9 Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009 ...
Tegning af konvertible lån fuldført
March 21, 2024 11:33 ET
|
Pharma Equity Group A/S
Tegning af konvertible lån fuldført 21. marts 2024Meddelelse nr. 08 Bestyrelsen i Pharma Equity Group besluttede den 7. februar 2024 at udstede konvertible lån i overensstemmelse med...
Completion of subscription of convertible loans
March 21, 2024 11:33 ET
|
Pharma Equity Group A/S
Completion of subscription of convertible loans March 21, 2024Company Announcement no. 08 On 7 February 2024, the Board of Directors of Pharma Equity Group decided to issue...
Correction: Pharma Equity Group A/S - Årsrapport 2023
March 20, 2024 12:15 ET
|
Pharma Equity Group A/S
Correction: Adding Annual Report in xhtml-file zip-format Pharma Equity Group A/S - Årsrapport 2023 Dato: 20. marts 2024 Årets meddelelse nr.: 07 Pharma Equity Group A/S - Årsrapport...
Correction: Pharma Equity Group A/S - Annual Report 2023
March 20, 2024 12:15 ET
|
Pharma Equity Group A/S
Correction: Adding Annual Report in xhtml-file zip-format Pharma Equity Group A/S - Annual Report 2023 Date: March 20, 2024Announcement of the Year No.: 7 Pharma Equity Group A/S - Annual...
Pharma Equity Group A/S - Årsrapport 2023
March 20, 2024 03:58 ET
|
Pharma Equity Group A/S
Pharma Equity Group A/S - Årsrapport 2023 Dato: 20. marts 2024 Årets meddelelse nr.: 07 Pharma Equity Group A/S - Årsrapport 2023 - året i hovedtræk Bestyrelsen for Pharma Equity Group A/S har dags...
Pharma Equity Group A/S - Annual Report 2023
March 20, 2024 03:58 ET
|
Pharma Equity Group A/S
Pharma Equity Group A/S - Annual Report 2023 Date: March 20, 2024Announcement of the Year No.: 7 Pharma Equity Group A/S - Annual report 2023 - main features of the year Today, the Board of...
Pharma Equity Groups datterselskab (Reponex Pharmaceuticals A/S) har modtaget meddelelse fra Det Europæiske Patentkontor (EPO) om beslutningen om at tildele deres patent for lægemiddelsammensætninger til fremme af sårheling (RNX-022).
March 05, 2024 04:11 ET
|
Pharma Equity Group A/S
Pharma Equity Groups datterselskab (Reponex Pharmaceuticals A/S) har modtaget meddelelse fra Det Europæiske Patentkontor (EPO) om beslutningen om at tildele deres patent for lægemiddelsammensætninger...
Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for promoting the healing of wounds (RNX-022).
March 05, 2024 04:11 ET
|
Pharma Equity Group A/S
Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for...